Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BEVA recognises equine vets in post-congress awards
Dr Victoria South wins the HBLB Award for her work on fatal laminitis.
Dr Julia Shrubb and Dr Victoria South received accolades.

The British Equine Veterinary Association (BEVA) has recognised the work of two veterinary surgeons, following its 2023 Congress.

Dr Julia Shrubb and Dr Victoria South were awarded their accolades for the clinical research they each presented at BEVA Congress this year.

The Sam Hignett Award was won by Dr Shrubb for her presentation of her research, ‘Understanding UK parasite control practices: A horse owner survey’. The project, the abstract of which is published in the Equine Veterinary Journal (EVJ), aims to investigate how horse owners control intestinal parasites in their horses in an effort to tackle anthelmintic resistance.

She wins free registration to this year’s AAEP Annual Convention in San Diego.

The Sam Hignett Award is presented annually, and is open to equine practice clinical research presented at BEVA Congress. It is named for Sam Hignett, former president of BEVA and the Royal College of Veterinary Surgeons, as well as the official veterinary surgeon for national and international horse events.

The HBLB Award goes to Dr Victoria South, a specialist in equine internal medicine at the University of Cambridge. Dr South presented research exploring the risk of fatal laminitis in horses hospitalised for a phallectomy compared to a laparatomy, the abstract of which is published in the EVJ.

The lead author of the paper, Dr Rachel Tucker, was unable to attend congress, so Dr South presented the research in her absence. Dr South was awarded free registration to BEVA Congress 2024, which can be transferred to a co-author if desired.

The HBLB Award, which replaces the Voorjaarsdagen and BEVA Award, is open to any clinical research abstract prevented at BEVA Congress.

This year’s winners were selected through continuous assessment during abstract submission and live presentation, using new scoring guidelines.

For the first time a clinical research sub-committee, chaired by Dr James Crabtree, was formed of members of the congress committee and independent expert volunteers. The committee reviewed and developed new scoring guidelines to select the winners.

Submissions were subject to blind peer review, and scored by at least two independent reviewers. Those which met EVJ criteria was reviewed, and the most meritorious and relevant were selected to be presented live at congress.

The highest scoring abstracts were judged live at BEVA Congress under either the HBLB or Sam Hignett award.

Dr Crabtree said: “These two award recipients have been through a rigorous process of review and have presented to an audience of peers in a stimulating and effective way and we celebrate this sharing of knowledge through these awards. Well done to you both!”

Abstract submissions for BEVA Congress 2024 open from 18 January 2024- 8 February 2024.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Zoetis apologises for EVA vaccine shortage

News Story 1
 Zoetis UK has apologised for a supply shortage of Equip Artervac, caused by a manufacturing issue.

It is expected to become available in June 2025.

Equip Artervac is used for the active immunisation for horses against equine viral arteritis (EVA) to reduce the clinical signs and shedding of the virus.

For more information, contact a Zoetis account manager or Zoetis Head Office on 0345 300 8034. 

Click here for more...
News Shorts
Bluetongue restricted zone extended

Following the discovery of a new case of bluetongue virus serotype 3 on the Buckinghamshire/Northamptonshire border, the restricted zone has been extended to include all of Northamptonshire.

The zone now covers Bedfordshire, Berkshire, Buckinghamshire, Cambridgeshire, City of Kingston upon Hull, East Riding of Yorkshire, East Sussex, Essex, Greater London, part of Hampshire, Hertfordshire, Kent, part of Leicestershire, Lincolnshire, Norfolk, Northamptonshire, Nottinghamshire, Suffolk, Surrey, and West Sussex.

Susceptible animals in the restricted zone should only be moved if it is essential. A specific licence is needed to move a susceptible animal from within the restricted zone to outside of the zone.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

A map of the area where movement restrictions apply can be found here.